2024/11/01 09:30:34 | |
---|---|
Price | |
39.015 EUR | |
Difference | 0.75% (0.29) |
ISIN | NL0015001WM6 |
Symbol | QGEN |
Exchange | Tradegate |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 8,582 EUR |
Benchmark | AMSTERDAM EXCHANGES INDEX |
Bid (Bid size) | 38.895 EUR (350) |
Ask (Ask size) | 38.90 EUR (350) |
Open | 39.015 EUR |
High | 39.015 EUR |
Low | 39.015 EUR |
Close (prev. day) | 38.725 EUR |
VWAP | 39.015 EUR |
Volume (pcs) | 12 |
Trading volume | 468.18 |
Number of trades | 2 |
Last size | 1 |
Related Futures | 38 |
Related Options | - |
Date | Headline | Download | |
2024/10/29 | Global Equity Ratings | ||
2024/10/29 | Aktienempfehlungen Global | ||
2024/10/22 | Global Equity Ratings | ||
2024/10/22 | Aktienempfehlungen Global | ||
2024/10/14 | Aktienempfehlungen Österreich |
2024/11/01 09:30:34 | |
---|---|
Price | |
39.015 EUR | |
Difference | 0.75% (0.29) |
ISIN | NL0015001WM6 |
Symbol | QGEN |
Exchange | Tradegate |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 8,582 EUR |
Benchmark | AMSTERDAM EXCHANGES INDEX |
Bid (Bid size) | 38.895 EUR (350) |
Ask (Ask size) | 38.90 EUR (350) |
Open | 39.015 EUR |
High | 39.015 EUR |
Low | 39.015 EUR |
Close (prev. day) | 38.725 EUR |
VWAP | 39.015 EUR |
Volume (pcs) | 12 |
Trading volume | 468.18 |
Number of trades | 2 |
Last size | 1 |
6M | 1Y | 3Y | |
Perf (%) | -2.43% | +5.96% | -22.25% |
Perf (abs.) | -0.97 | +2.18 | -11.08 |
Beta | 0.42 | 0.37 | 0.51 |
Volatility | 22.15 | 21.00 | 22.21 |
Ø price 5 days | Ø volume 5 days (pcs.) | 38.718 EUR (2,828) |
Ø price 30 days | Ø volume 30 days (pcs.) | 39.663 EUR (10,039) |
Ø price 100 days | Ø volume 100 days (pcs.) | 39.990 EUR (6,429) |
Ø price 250 days | Ø volume 250 days (pcs.) | 40.000 EUR (6,165) |
YTD High | date | 43.340 EUR (2024/01/16) |
YTD Low | date | 36.015 EUR (2024/04/19) |
52 Weeks High | date | 43.340 EUR (2024/01/16) |
52 Weeks Low | date | 36.015 EUR (2024/04/19) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/11/01 | 10:09 | 38.925 EUR | 0.99 | 374 |
Vienna Stock Exchange | 2024/10/31 | 17:32 | 38.99 EUR | 0.00 | 4 |
Tradegate | 2024/11/01 | 09:30 | 39.015 EUR | 0.00 | 2 |
Stuttgart | 2024/11/01 | 10:05 | 38.905 EUR | 0.03 | 25 |
NYSE | 2024/10/31 | 21:00 | 42.10 USD | 39.05 | 11,314 |
Munich | 2024/11/01 | 08:00 | 38.775 EUR | 0.00 | 1 |
London Stock Exchange European Trade Reporting | 2024/10/31 | 17:30 | 43.54 EUR | 0.00 | 1 |
Hanover | 2024/11/01 | 08:16 | 38.58 EUR | 0.00 | 1 |
Hamburg | 2024/11/01 | 08:16 | 38.58 EUR | 0.00 | 1 |
Frankfurt | 2024/11/01 | 08:22 | 38.575 EUR | 0.00 | 1 |
Euronext Milan MTF Trading After Hours | 2024/04/08 | 18:55 | 39.18 EUR | 0.00 | 1 |
Euronext Milan MTF Global Equity Market | 2024/10/31 | 17:44 | 38.94 EUR | 0.00 | 1 |
Duesseldorf | 2024/11/01 | 09:32 | 38.995 EUR | 0.00 | 2 |
Berlin | 2024/11/01 | 08:00 | 38.755 EUR | 0.00 | 1 |
QIAGEN NV |
- - |
Hulsterweg 82 - 5912 PL Venlo |
Telefon: +31-77-355-66-00 |
Fax: + |
E-mail: qiagen@qiagen.com |
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands. |
Thierry Bernard | Chairman of Managing Board |
Jonathan Sheldon | Member of Executive Committee |
Antonio Santos | Member of Executive Committee |
Fernando Beils | Member of Executive Committee |
Jean-Pascal Viola | Member of Executive Committee |
Nitin Sood | Member of Executive Committee |
Roland Sackers | Member of Executive Committee |
Stephany Foster | Member of Executive Committee |
Lawrence Rosen | Chairman of Supervisory Board |
Elaine Mardis | Member of Supervisory Board |
Eva Pisa | Member of Supervisory Board |
Metin Colpan | Member of Supervisory Board |
Ross Levine | Member of Supervisory Board |
Toralf Haag | Member of Supervisory Board |
Bert van Meurs | Member of Supervisory Board |
Elizabeth Tallett | Member of Supervisory Board |
Eva van Pelt | Member of Supervisory Board |
Stephen Rusckowski | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).
The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.
Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.
The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.
By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.